Barely Significant
← all excerpts

Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial.

Pharmaceutics · 2021 · PMC8618458 · PMID 34834183

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantp < 0.01actually significant
Patients in the Device Group needed a highly significant ( p < 0.01) intensive oxygen therapy to overcome hypoxemia.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.